Quantitative analysis showed that tumor size and number was significantly reduced in mice treated with BEZ235 and IR than mice treated with either modality alone, further suggesting that inhibiting PI3K/AKT/mTOR pathway sensitized SCLC cells to radiation in vivo (Fig. 8F). The gene discussed is AKT1; the disease is neoplasm.